Peptides for GH Research
Growth-hormone research typically pairs a GHRH analog with a GH secretagogue for pulsatile-release research models. Ares carries the full family.
Mechanism & research context
GHRH analogs (CJC-1295 with and without DAC, tesamorelin, sermorelin) act at the pituitary GHRH receptor. GH secretagogues (ipamorelin, hexarelin) act at the ghrelin receptor. Combined administration is the most commonly referenced research protocol.
Referenced compounds
Recombinant growth hormone studied in endocrine signaling research.
Long-acting GHRH analog with DAC examined in growth hormone signaling research.
Synthetic GHRH analog without DAC, studied in growth hormone signaling research.
Selective peptide examined in growth hormone secretagogue research.
Synthetic GHRH analog used in endocrine signaling research.
Studied in growth hormone secretion and peptide signaling research models.
Pegylated mechano-growth factor analog studied in advanced growth and tissue signaling research models.
Research-grade peptide studied in growth factor signaling and cellular pathway research.
Research questions
- Why is CJC-1295 paired with ipamorelin in research?
- CJC-1295 is a GHRH analog and ipamorelin is a selective GH secretagogue — the two act on complementary receptors, and the combined pulse is the most frequently referenced GH research protocol.
- What is the difference between CJC-1295 with and without DAC?
- DAC (Drug Affinity Complex) extends CJC-1295's half-life from hours to days by binding serum albumin, producing sustained GHRH exposure in research models.
All Ares Research Lab compounds are intended strictly for research and laboratory use only. Not for human consumption. Every lot ships with COA on request — HPLC purity, MS confirmation, and endotoxin data.